Clinical Trials

115 enrolled

Other solid neoplasm

Solid Tumor

NCT05845138 2023-08-01

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

116 enrolled

Breast Neoplasms

NCT05964543 2023-07-28

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

72 enrolled

Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT04522284 2023-03-29

PRECISE CURATE.AI Pilot Clinical Trial

20 enrolled

Lymphoid

Waldenstrom Macroglobulinemia, Neoplasms

NCT01898104 2023-03-24

V-shoRT-R3

152 enrolled

Colorectal Neoplasms

NCT05608785 2022-11-08

Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes

45 enrolled

Stomach Neoplasms

NCT04782804 2022-08-18

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

30 enrolled

Cholangiocarcinoma

NCT05016869 2022-08-18

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

48 enrolled

Colorectal Neoplasms

NCT05235542 2022-08-11

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

130 enrolled

Advanced Malignant Tumors

NCT03805399 2022-08-10

FUTURE

140 enrolled

Triple Negative Breast Neoplasms

NCT02948348 2021-09-16

Study to Nivolumab Following Preoperative Chemoradiotherapy

90 enrolled

Rectal Neoplasms

NCT04943653 2021-07-06

IPXELOX

61 enrolled

Stomach Neoplasms

NCT02901301 2021-04-06

Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer

41 enrolled

Stomach Neoplasms

NCT04380103 2020-05-08

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

106 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT04202978 2020-04-16

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

23 enrolled

Hepatic Metastasis of Colorectal Cancer

NCT04227041 2020-01-14

A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer

34 enrolled

HER-2 Positive Colorectal Cancer

NCT04008511 2019-07-05

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

54 enrolled

Colorectal Neoplasms

NCT02422199 2018-07-09

A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab

128 enrolled

HER2 Positive Metastatic Breast Cancer

NCT01716949 2017-08-11

HyRec

59 enrolled

Hyperthermia, Rectal Neoplasms

NCT00726687 2012-07-19

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

7 enrolled

Tumor-Agnostic

Neoplasms

NCT01348009 2012-03-13

Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer

63 enrolled

Stomach Neoplasms

NCT00821912 2012-02-28

TaxXel

93 enrolled

Esophageal Neoplasms

NCT01079702 2010-03-03

m-TOR

35 enrolled

Advanced Malignancies

NCT00496704 2009-08-21

Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan

56 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00845884 2009-02-18

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

49 enrolled

Tumor-Agnostic

Neoplasms

NCT00324610 2006-05-18

Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen

46 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00081536 2005-06-24

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

105 enrolled